Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1100 participants.

Also called NCT06243133

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06243133
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06243133. Randomized; single masking; primary purpose treatment. Start 2024-07-01 (anticipated); primary completion 2026-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
Acronym
PATH-ICAS
Condition
Intracranial Arteriosclerosis
Condition
Secondary Prevention
Condition
Antiplatelet Drug
Intervention (Drug)
clopidogrel for 90 days combined with aspirin for 90 days
Intervention (Drug)
clopidogrel for 30 days combined with aspirin for 90 days
Lead sponsor
Sichuan Provincial People's Hospital (class: other)

Record details

Record id
cardio:ct-nct06243133
Content hash
d780ac7955c7e501c91526103df18200617a7557cf060516331dc8eb2a91461b